Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Laursen

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1989
Monoclonal antibodies reactive with components in serum-free conditioned medium from a human breast cancer cell line (MCF-7)T B Kjeldsen, I Laursen, A Lykkesfeldt, et al.
European Journal of Cell Biology|December 1, 1989
Effect of insulin on growth and expression of smooth muscle isoactin in human breast gland myoepithelial cells in a chemically defined culture systemO W Petersen, S H Hansen, I Laursen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 14, 2007
Comparison of rocket and crossed immuno-electrophoresis assays for determination of the level of actin complexing of Gc globulinC S Jørgensen, F V Schiødt, B Dahl, et al.
Cancer Research|March 1, 1992
Altered gene expression of c-myc, epidermal growth factor receptor, transforming growth factor-alpha, and c-erb-B2 in an immortalized human breast epithelial cell line, HMT-3522, is associated with decreased growth factor requirementsM W Madsen, A E Lykkesfeldt, I Laursen, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1988
Oestrogen reversible inhibitory activity of sera from breast cancer patients [corrected]A E Lykkesfeldt, C Rose, S M Thorpe, et al.
The British Journal of Dermatology|June 3, 1999
Fetal antigen 1, a member of the epidermal growth factor superfamily, in neurofibromas and serum from patients with neurofibromatosis type 1C H Jensen, H D Schroder, B Teisner, et al.
Vox Sanguinis|April 26, 2007
Second-generation nanofiltered plasma-derived mannan-binding lectin product: process and characteristicsI Laursen, G Houen, P Højrup, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|April 30, 2004
Gc globulin (vitamin D-binding protein) levels: an inhibition ELISA assay for determination of the total concentration of Gc globulin in plasma and serumC S Jørgensen, M Christiansen, B Nørgaard-Pedersen, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|July 9, 1998
EPR and DNP properties of certain novel single electron contrast agents intended for oximetric imagingJ H Ardenkjaer-Larsen, I Laursen, I Leunbach, et al.
Cancer Research|February 15, 1990
Differential tumorigenicity of two autologous human breast carcinoma cell lines, HMT-3909S1 and HMT-3909S8, established in serum-free mediumO W Petersen, B van Deurs, K V Nielsen, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1989
Monoclonal antibodies reactive with components in serum-free conditioned medium from a human breast cancer cell line (MCF-7)T B Kjeldsen, I Laursen, A Lykkesfeldt, et al.
European Journal of Cell Biology|December 1, 1989
Effect of insulin on growth and expression of smooth muscle isoactin in human breast gland myoepithelial cells in a chemically defined culture systemO W Petersen, S H Hansen, I Laursen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 14, 2007
Comparison of rocket and crossed immuno-electrophoresis assays for determination of the level of actin complexing of Gc globulinC S Jørgensen, F V Schiødt, B Dahl, et al.
Cancer Research|March 1, 1992
Altered gene expression of c-myc, epidermal growth factor receptor, transforming growth factor-alpha, and c-erb-B2 in an immortalized human breast epithelial cell line, HMT-3522, is associated with decreased growth factor requirementsM W Madsen, A E Lykkesfeldt, I Laursen, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1988
Oestrogen reversible inhibitory activity of sera from breast cancer patients [corrected]A E Lykkesfeldt, C Rose, S M Thorpe, et al.
The British Journal of Dermatology|June 3, 1999
Fetal antigen 1, a member of the epidermal growth factor superfamily, in neurofibromas and serum from patients with neurofibromatosis type 1C H Jensen, H D Schroder, B Teisner, et al.
Vox Sanguinis|April 26, 2007
Second-generation nanofiltered plasma-derived mannan-binding lectin product: process and characteristicsI Laursen, G Houen, P Højrup, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|April 30, 2004
Gc globulin (vitamin D-binding protein) levels: an inhibition ELISA assay for determination of the total concentration of Gc globulin in plasma and serumC S Jørgensen, M Christiansen, B Nørgaard-Pedersen, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|July 9, 1998
EPR and DNP properties of certain novel single electron contrast agents intended for oximetric imagingJ H Ardenkjaer-Larsen, I Laursen, I Leunbach, et al.
Cancer Research|February 15, 1990
Differential tumorigenicity of two autologous human breast carcinoma cell lines, HMT-3909S1 and HMT-3909S8, established in serum-free mediumO W Petersen, B van Deurs, K V Nielsen, et al.
Pageof 3